Workflow
Moderna Expects Lower Annual Sales, Expands Cost-Cutting Initiatives
MRNAModerna(MRNA) Benzinga·2025-01-13 22:33

Moderna Inc. MRNA stock plunged on Monday after the company announced business updates and progress across its pipeline. Moderna says it enters 2025 with a focus on a prioritized portfolio addressing respiratory viruses, rare diseases, oncology, and latent and other viruses.The company will present at the 43rd Annual J.P. Morgan Healthcare Conference.In September, Moderna unveiled key updates at its annual R&D Day by reducing annual R&D spending by $1.1 billion by 2027, enabling a focus on ten prioritized p ...